MicroPort CardioFlow Medtech Corporation
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People's Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valv… Read more
MicroPort CardioFlow Medtech Corporation - Asset Resilience Ratio
MicroPort CardioFlow Medtech Corporation (MROPF) has an Asset Resilience Ratio of 37.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how MicroPort CardioFlow Medtech Corporation's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down MicroPort CardioFlow Medtech Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $987.89 Million | 37.03% |
| Total Liquid Assets | $987.89 Million | 37.03% |
Asset Resilience Insights
- Very High Liquidity: MicroPort CardioFlow Medtech Corporation maintains exceptional liquid asset reserves at 37.03% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
MicroPort CardioFlow Medtech Corporation Industry Peers by Asset Resilience Ratio
Compare MicroPort CardioFlow Medtech Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for MicroPort CardioFlow Medtech Corporation (2022–2024)
The table below shows the annual Asset Resilience Ratio data for MicroPort CardioFlow Medtech Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 46.74% | $1.25 Billion | $2.68 Billion | +19.26pp |
| 2023-12-31 | 27.48% | $708.27 Million | $2.58 Billion | +20.52pp |
| 2022-12-31 | 6.96% | $208.94 Million | $3.00 Billion | -- |